Jianhai Technology Secures RMB 500 Million in Series B+ Funding and Launches 'Encyclopedia Thousand Hospitals' Initiative

On November 8, 2021, Hangzhou Jianhai Science and Technology Co., Ltd. (hereinafter referred to as “Jianhai Tech”) completed a RMB 500 million Series B+ financing round. The round was led by China Renaissance New Economy Fund, with participation from Sanzheng Health, Sequoia China, and Guoce Investment, while other existing shareholders continued to increase their investments. Probe Capital continued to serve as the exclusive financial advisor for Jianhai Tech in this financing round.

Jianhai Technology, founded in 2015, adheres to the philosophy of “making care a potent remedy” and focuses on the development and operational delivery of post-diagnosis disease management services. The company has currently partnered with over 1,000 hospitals and facilitated the integration of multiple specialized digital therapeutics vendors into these institutions to benefit more patients. This round of financing will be dedicated to building an ecosystem for post-diagnosis disease management infrastructure and service operations. Meanwhile, Jianhai will launch the “Baike Qianyuan” (Encyclopedia Thousand Hospitals) Initiative to serve more partners in specialized disease management and digital therapeutics, jointly fostering China’s ecosystem for post-diagnosis disease management and digital therapeutics.